Application of EZH2 (enhancer of zeste homolog 2) inhibitor compounds in preparation of drugs for treating eye melanoma
作者： Fan Xianqun , Wen Xuyang , Ge Shengfang , Chai Peiwei , Zhang He
DOI:
关键词:
摘要: The invention discloses application of EZH2 (enhancer zeste homolog 2) inhibitor compounds in the preparation drugs for treating eye melanoma; include GSK503, GSK343, EPZ005687 and EPZ-6438, having molecular formulas C31H38N6O2, C31H39N7O2, C34H44N4O4 C32H37N5O3, structural which are shown description. is intended to provide novel targets clinical treatment melanoma, effectiveness improved, ball extraction rate reduced, vision prognosis patient a field exploited unprecedentedly.
lens.org 参考文章(4)
Klaus G. Griewank, Henrike Westekemper, Rajmohan Murali, Monika Mach, Bastian Schilling, Thomas Wiesner, Tobias Schimming, Elisabeth Livingstone, Antje Sucker, Florian Grabellus, Claudia Metz, Daniela Süsskind, Uwe Hillen, Michael R. Speicher, Scott E. Woodman, Klaus-Peter Steuhl, Dirk Schadendorf, Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas Clinical Cancer Research. ,vol. 19, pp. 3143- 3152 ,(2013) , 10.1158/1078-0432.CCR-13-0163
Victoria Marie Richon, Christopher John Sneeringer, Sarah Kathleen Knutson, Kevin Wayne Kuntz, Margaret Davis Scott, Robert Allen Copeland, Roy Macfarlane Pollock, Inhibitors of human ezh2, and methods of use thereof ,(2011)
Ellen H. Filvaroff, Ida Aronchik, Gordon L. Bray, Carmen Maria Barnes, Combinations of an erk inhibitor and a cdk4/6 inhibitor and related methods ,(2015)
Ross Levine, Omar Abdel-Wahab, Lindsay Lafave, Biomarkers for response to ezh2 inhibitors ,(2015)